Ghent University Academic Bibliography

Assessing the persistence and relevance of small T‐LGL clones via TRBC1 in a flowcytometric lymphoid screening tube

Nathan Debunne (UGent) , Barbara Cauwelier, Helena Devos, Sylvia Snauwaert and Jan Emmerechts

(2025) INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY. 47(6). p.1083-1088

Journal Article
A1
open access

Risk factors and outcome of HHV-6 infections after allogeneic hematopoietic cell transplantation

Stefanie De Vlieger (UGent) , Juliette Van Hoorde, Ineke van Gremberghe (UGent) , Sylvia Snauwaert, Jan Van Droogenbroeck (UGent) , Tom Lodewyck, Alexander Schauwvlieghe (UGent) , Dominik Selleslag, Marijke Reynders and Jens Van Praet (UGent)

(2025) OPEN FORUM INFECTIOUS DISEASES. 12(7).

Add to list

Fixed-duration epcoritamab in combination with bendamustine plus Rituximab (BR) for first-line (IL) treatment of follicular lymphoma (FL) : 3-year results from EPCORE NHL-2 arm 3 demonstrate deep and durable responses with manageable safety

Umberto Vitolo, Lorenzo Falchi, Sylvia Snauwaert, Fritz Offner (UGent) , Marcel Nijland, Per-Ola Andersson, Poliana Patah, Isil Altintas, Jennifer Marek, Malene Risum, et al.

(2025) BLOOD. In Blood 146(Supplement 1). p.5357-5358

Add to list

Fixed-duration epcoritamab plus R-CHOP in newly diagnosed diffuse large B-cell lymphoma : EPCORE NHL-2 update

Lorenzo Falchi, Fritz Offner (UGent) , Sven de Vos, Joshua D. Brody, Raul Cordoba, Kim M. Linton, Sylvia Snauwaert, Michael Roost Clausen, Toshihiko Oki, Andrew J. Steele, et al.

(2025) BRITISH JOURNAL OF HAEMATOLOGY. In British Journal of Haematology 206(Supplement 1). p.185-185

Add to list

Fixed-duration epcoritamab plus R-CHOP in patients with newly diagnosed DLBCL and high IPI scores (3-5) led to sustained remissions and disease-free survival beyond 3 years : results from the EPCORE NHL-2 trial

Lorenzo Falchi, Fritz Offner (UGent) , Sven de Vos, Joshua Brody, Daniel Morillo, Kim Linton, Sylvia Snauwaert, Michael Roost Clausen, Raul Cordoba, Toshihiko Oki, et al.

(2025) BLOOD. In Blood 146(Supplement 1). p.1955-1956

Add to list

Journal Article
A1
open access

Epidemiological characteristics and outcome of viral respiratory tract infections in the first year after allogeneic hematopoietic cell transplantation

Jens Van Praet (UGent) , Andreas Huysman, Eline De Knijf, Stefanie De Buyser (UGent) , SYLVIA SNAUWAERT (UGent) , Jan Van Droogenbroeck, Tom Lodewyck, Alexander Schauwvlieghe (UGent) , Dominik Selleslag and Marijke Reynders

(2024) JOURNAL OF INFECTIOUS DISEASES. 230(4). p.944-948

Add to list

Fixed-duration epcoritamab in combination with bendamustine plus rituximab for first-line treatment of follicular lymphoma : initial results from Epcore NHL-2 Arm 3

Joshua Brody, Lorenzo Falchi, Umberto Vitolo, Marcel Nijland, Fritz Offner (UGent) , Sylvia Snauwaert, Poliana Patah, Jennifer Marek, Christopher Morehouse, Andrew J. Steele, et al.

(2024) BLOOD. In Blood 144(Supplement 1). p.1627-1628

Add to list

Fixed-duration epcoritamab plus R-CHOP induces high complete response rates in patients with previously untreated diffuse large B-cell lymphoma with high-risk features : long-term results from the Epcore NHL-2 trial

Lorenzo Falchi, Fritz Offner (UGent) , Sven de Vos, Joshua Brody, Raul Cordoba, Kim Linton, Sylvia Snauwaert, Michael Roost Clausen, Toshihiko Oki, Andrew J. Steele, et al.

(2024) BLOOD. In Blood 144(Supplement 1). p.581-582

Add to list

Journal Article
A1
open access

Impact of model-informed precision dosing in adults receiving vancomycin via continuous infusion : a randomized, controlled clinical trial

Glenn Van Wynsberge (UGent) , Veerle Grootaert, Franky Buyle (UGent) , Jens Van Praet (UGent) , Roos Colman (UGent) , Ine Moors (UGent) , Annemie Somers (UGent) , Diana Huis in 't Veld (UGent) , Pieter De Cock (UGent) , Kim Bigler, et al.

(2024) TRIALS. 25(1).

Add to list

Journal Article
A1
open access

Infectious diarrhea after allogeneic hematopoietic cell transplantation assessed by a multiplex polymerase chain reaction assay

Jens Van Praet (UGent) , Andreas Huysman, Eline De Knijf, Stefanie De Buyser (UGent) , Sylvia Snauwaert, Jan Van Droogenbroeck (UGent) , Tom Lodewyck, Alexander Schauwvlieghe (UGent) , Dominik Selleslag and Marijke Reynders

(2023) INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 127. p.17-22

Academic Bibliography

Assessing the persistence and relevance of small T‐LGL clones via TRBC1 in a flowcytometric lymphoid screening tube

Risk factors and outcome of HHV-6 infections after allogeneic hematopoietic cell transplantation

Fixed-duration epcoritamab in combination with bendamustine plus Rituximab (BR) for first-line (IL) treatment of follicular lymphoma (FL) : 3-year results from EPCORE NHL-2 arm 3 demonstrate deep and durable responses with manageable safety

Fixed-duration epcoritamab plus R-CHOP in newly diagnosed diffuse large B-cell lymphoma : EPCORE NHL-2 update

Fixed-duration epcoritamab plus R-CHOP in patients with newly diagnosed DLBCL and high IPI scores (3-5) led to sustained remissions and disease-free survival beyond 3 years : results from the EPCORE NHL-2 trial

Epidemiological characteristics and outcome of viral respiratory tract infections in the first year after allogeneic hematopoietic cell transplantation

Fixed-duration epcoritamab in combination with bendamustine plus rituximab for first-line treatment of follicular lymphoma : initial results from Epcore NHL-2 Arm 3

Fixed-duration epcoritamab plus R-CHOP induces high complete response rates in patients with previously untreated diffuse large B-cell lymphoma with high-risk features : long-term results from the Epcore NHL-2 trial

Impact of model-informed precision dosing in adults receiving vancomycin via continuous infusion : a randomized, controlled clinical trial

Infectious diarrhea after allogeneic hematopoietic cell transplantation assessed by a multiplex polymerase chain reaction assay

Contents

Support

Contact